Helmer Martins Tate & Garrett Co., LPA, partner B. Nathaniel Garrett was quoted in a December 24, 2025 Bloomberg Law article regarding the significant False Claims Act appeals anticipated in 2026.
Nathaniel corresponded with Bloomberg Law reporter Daniel Seiden and provided his thoughts on what’s shaping up to be a pivotal year for False Claims Act litigation. Following a year marked by major FCA trials and substantial jury verdicts, 2026 is expected to bring crucial appellate decisions that will impact FCA litigants across the board.
“There is a lot at stake in these appeals, not only for the litigants in those cases but to all litigants in the FCA space,” said Nathaniel.
Bloomberg Law’s article examines the implications of upcoming appeals, including those involving major corporations like Johnson & Johnson and CVS, as they challenge significant False Claims Act judgments.
To read the full article and gain deeper insight into what 2026 holds for False Claims Act litigation, visit: J&J Unit, CVS Take Aim at Big False Claims Act Judgments in 2026
HMTG is proud to be a recognized leader in False Claims Act litigation. Our firm appreciates the opportunity to share its thoughts with Bloomberg Law and remains committed to keeping our clients informed about important developments in False Claims Act litigation.